CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Net service revenue	$ 557,890	$ 564,166	$ 1,103,147	$ 1,101,310
Other operating income	0	4,603	0	13,304
Cost of service, excluding depreciation and amortization	316,211	308,691	621,031	605,894
General and administrative expenses:
Salaries and benefits	127,758	114,335	251,238	230,160
Non-cash compensation	5,148	6,156	12,495	13,463
Other	54,912	54,731	108,552	103,837
Depreciation and amortization	6,220	6,721	14,228	14,276
Operating expenses	510,249	490,634	1,007,544	967,630
Operating income	47,641	78,135	95,603	146,984
Other income (expense):
Interest income	36	25	49	49
Interest expense	(8,311)	(1,932)	(11,484)	(4,004)
Equity in earnings (loss) from equity method investments	659	1,370	(744)	2,488
Gain on equity method investments	0	31,092	0	31,092
Miscellaneous, net	331	475	664	763
Total other (expense) income, net	(7,285)	31,030	(11,515)	30,388
Income before income taxes	40,356	109,165	84,088	177,372
Income tax expense	(11,319)	(28,546)	(23,338)	(46,461)
Net income	29,037	80,619	60,750	130,911
Net loss (income) attributable to noncontrolling interests	542	(470)	500	(892)
Net income attributable to Amedisys, Inc.	$ 29,579	$ 80,149	$ 61,250	$ 130,019
Basic earnings per common share:
Net income attributable to Amedisys, Inc. common stockholders, basic (usd per share)	$ 0.91	$ 2.46	$ 1.88	$ 3.98
Weighted average shares outstanding, basic (shares)	32,522	32,588	32,538	32,684
Diluted earnings per common share:
Net income attributable to Amedisys, Inc. common stockholders, diluted (usd per share)	$ 0.91	$ 2.43	$ 1.87	$ 3.93
Weighted average shares outstanding, diluted (shares)	32,681	32,981	32,722	33,085